00078-0709 TABRECTA - CanMED: NDC

Product NDC:

00078-0709

Brand Name:

TABRECTA

Generic Name:

Capmatinib

Dosage Form Name:

TABLET, FILM COATED

Administration Route:

Oral

Substances:

Name: CAPMATINIB HYDROCHLORIDE

Strength: 150.0

Unit: mg/1

Packages:

Code: 00078-0709-56

Description: 56 TABLET, FILM COATED in 1 BOTTLE (0078-0709-56)

Effective Date: May 6, 2020

Discontinued:

Code: 00078-0709-94

Description: 56 TABLET, FILM COATED in 1 BOTTLE (0078-0709-94)

Effective Date: May 6, 2020

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

MET

Orphan Drug Designation:

Yes

Status:

In Use

CanMED and the Oncology Toolbox